Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

29
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NLRP3 facilitates α-synuclein-induced dopaminergic neuronal senescence in a mouse model of Parkinson's disease through SATB1/DNA damage/p21 signaling pathway.

Acta pharmacologica Sinica·2025
Same author

Clinical validation of artificial intelligence-assisted karyotyping on peripheral blood in a cytogenetic diagnostic laboratory.

Human genetics·2025
Same author

A universal and cost-efficient sample labeling approach for multiplexed single-cell RNA-seq based on recombinant HUH-endonuclease-agglutinin tagging.

Journal of genetics and genomics = Yi chuan xue bao·2025
Same author

ELF5 modulates casein synthesis in goat mammary epithelial cells via JAK2/STAT5 signaling pathway.

Animal bioscience·2025
Same author

Identification of diabetes related phenotype and diagnostic biomarkers in coronary artery disease.

PeerJ·2025
Same author

TRAIL-mediated armA upregulation enhances the drug resistance of <i>Klebsiella pneumoniae</i> by activating the PI3K/AKT/mTOR signaling pathway.

American journal of translational research·2025

Related Experiment Video

Updated: May 3, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.2K

[GBA mutations and Parkinson's disease].

Dong-Xia Wang1, Jun-Xia Xie1, Ning Song2

  • 1Department of Physiology and Pathophysiology, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao 266071, China.

Sheng Li Xue Bao : [Acta Physiologica Sinica]
|June 22, 2018
PubMed
Summary

Genetic mutations in the GBA gene are the largest risk factor for Parkinson's disease (PD). GBA mutations cause Gaucher disease and are linked to PD pathogenesis, creating a vicious cycle impacting alpha-synuclein and GCase function.

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

11.6K

Related Experiment Videos

Last Updated: May 3, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.2K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

14.9K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

11.6K

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Parkinson's disease (PD) involves dopaminergic neuron degeneration and Lewy bodies.
  • GBA gene mutations are the primary genetic risk factor for PD.
  • Gaucher disease (GD) patients with GBA mutations often exhibit parkinsonian symptoms.

Purpose of the Study:

  • To review the current understanding of the link between GBA mutations and PD pathogenesis.
  • To explore the bidirectional relationship between GBA mutations, alpha-synuclein, and GCase function in PD.
  • To provide insights into PD etiology and potential therapeutic targets.

Main Methods:

  • Literature review of studies on GBA mutations, Gaucher disease, and Parkinson's disease.
  • Analysis of the molecular mechanisms linking GBA variants to alpha-synuclein pathology and GCase dysfunction.
  • Synthesis of current knowledge on the bidirectional pathogenic loop in PD.

Main Results:

  • GBA mutations are strongly associated with PD, particularly earlier onset and cognitive decline.
  • GCase loss-of-function due to GBA mutations impairs alpha-synuclein degradation.
  • Alpha-synuclein pathology exacerbates GCase dysfunction, forming a pathogenic cycle.

Conclusions:

  • GBA mutations represent a significant risk factor and play a crucial role in PD pathogenesis.
  • The interplay between GBA, alpha-synuclein, and GCase offers potential therapeutic avenues for PD.
  • Further elucidation of these mechanisms is needed for novel PD treatments.